T1	Disorder 22 50	systemic lupus erythematosus
N1 	Reference T1 UMLS:C0024141	systemic lupus erythematosus
T2	Pharmacological_substance 54 70	interferon-gamma
N1000 	Reference T2 MeSH:D007371	interferon-gamma
T4	Disorder 89 109	rheumatoid arthritis
N2 	Reference T4 UMLS:C0003873	rheumatoid arthritis
T5	Disorder 131 159	systemic lupus erythematosus
N3 	Reference T5 UMLS:C0024141	systemic lupus erythematosus
T6	Disorder 161 164	SLE
N4 	Reference T6 UMLS:C0024141	SLE
N5 	Reference T6 UMLS:C0014060	SLE
N6 	Reference T6 UMLS:C0024141	SLE
T10	Pharmacological_substance 198 209;216 232	recombinant interferon gamma
T11	Pharmacological_substance 234 244	rIFN-gamma
T12	Disorder 277 297	rheumatoid arthritis
N7 	Reference T12 UMLS:C0003873	rheumatoid arthritis
T13	Disorder 314 332	glomerulonephritis
N8 	Reference T13 UMLS:C0017658	glomerulonephritis
T18	Pharmacological_substance 464 474	rIFN-gamma
T19	Disorder 510 513	SLE
N9 	Reference T19 UMLS:C0024141	SLE
N10 	Reference T19 UMLS:C0014060	SLE
N11 	Reference T19 UMLS:C0024141	SLE
T3	Subject 264 271	patient
T7	Disorder 339 353	butterfly rash
N12 	Reference T7 UMLS:C0277942	butterfly rash
T16	Subject 76 83	patient
T20	Speculation_cue 452 458	assume
